Fundraising FoxTissue Genesis, Inc
Honolulu, US
Find your way into Tissue Genesis, Inc
Sign up to see every warm intro you have to Tissue Genesis, Inc
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tissue Genesis, Inc team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Tissue Genesis makes the Icellator2, an automated, enclosed system that isolates stromal vascular fraction (SVF) stem cells from adipose tissue in about an hour using its proprietary Adipase enzyme and single-use kits. The system targets clinics, operating rooms, and research labs, and is approved for clinical use in The Bahamas while under FDA IDE clinical studies in the USA.
Founders & leadership
Board
Reported raises · per SEC filings
Form D private placements$8.2M disclosed across 2 rounds · 2011–2014
▶$500KraisedSep 2014 · 1 investors · BiotechnologyRule 506(b)
- Lawrence RodriguezDirector
- Paul KosnikExecutive Officer
- Michael RuleyDirector
- Anton C. KruckyExecutive Officer, Director
- Robert HiamDirector
- Timothy SarhattDirector
- Thomas CannonExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $500K
- Minimum investment
- $25K
- Proceeds to insiders
- $120K
- First sale
- Aug 2014
- Incorporated
- Corporation, Hawaii
- Federal exemptions
- 06b
▶$7.7MraisedJan 2012 · 53 investors · BiotechnologyRule 506(b)
- Michael RuleyDirector
- Paul KosnikExecutive Officer
- Anton C KruckyExecutive Officer, Director
- Robert HiamDirector
- Jeffrey WatanabeDirector
- Thomas CannonExecutive Officer, Director
- Offering amount
- $15.3M
- Amount sold
- $7.7M
- Minimum investment
- $10K
- First sale
- Dec 2011
- Incorporated
- Corporation, Hawaii
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity takenSource: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Tissue Genesis, Inc do?
- Tissue Genesis makes the Icellator2, an automated, enclosed system that isolates stromal vascular fraction (SVF) stem cells from adipose tissue in about an hour using its proprietary Adipase enzyme and single-use kits. The system targets clinics, operating rooms, and research labs, and is approved for clinical use in The Bahamas while under FDA IDE clinical studies in the USA.
- How much funding has Tissue Genesis, Inc raised?
- Tissue Genesis, Inc has disclosed $8.2M raised across 2 rounds.
- Where is Tissue Genesis, Inc headquartered?
- Tissue Genesis, Inc is headquartered in Honolulu, US.